Status epilepticus and COVID-19: A systematic review
暂无分享,去创建一个
M. Onofrj | L. Bonanni | G. Assenza | Francesco Brigo | C. Vollono | F. Anzellotti | J. Lanzone | M. di Pietro | F. Dono | Giacomo Evangelista | Lorenzo Tinti | M. Russo | F. Rinaldi | Serena Troisi | B. Nucera | Rino Speranza | G. Evangelista | S. Troisi | R. Speranza
[1] L. Nashef,et al. New-onset refractory status epilepticus (NORSE) , 2021, Practical Neurology.
[2] T. Solomon. Neurological infection with SARS-CoV-2 — the story so far , 2021, Nature Reviews Neurology.
[3] C. June,et al. Cytokine Storm , 2020, The New England journal of medicine.
[4] C. Conrad,et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 , 2020, Nature Neuroscience.
[5] N. Issa,et al. Epileptiform activity and seizures in patients with COVID-19 , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[6] Sean T. Hwang,et al. Acute Seizures Occurring in Association With SARS-CoV-2 , 2020, Frontiers in Neurology.
[7] M. Onofrj,et al. New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report , 2020, Neurological Sciences.
[8] U. Siebert,et al. Status epilepticus admissions during the COVID‐19 pandemic in Salzburg—A population‐based study , 2020, Epilepsia.
[9] R. Soto-Rifo,et al. A suspected case of SARS-CoV-2 persistence with reactivation , 2020 .
[10] D. Houinato,et al. COVID-19 infection in known epileptic and non-epileptic children: what is the place of chloroquine sulfate? (a case report) , 2020, The Pan African medical journal.
[11] P. Troncoso,et al. EEG findings and clinical prognostic factors associated with mortality in a prospective cohort of inpatients with COVID-19 , 2020, Seizure.
[12] F. Brunnhuber,et al. Non-convulsive status epilepticus: COVID-19 or clozapine induced? , 2020, BMJ Case Reports.
[13] F. Nikbakht,et al. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms , 2020, Multiple Sclerosis and Related Disorders.
[14] A. Akbari,et al. Seizure in patients with COVID-19 , 2020, Neurological Sciences.
[15] K. Melmed,et al. Post–COVID‐19 inflammatory syndrome manifesting as refractory status epilepticus , 2020, Epilepsia.
[16] A. Saeed,et al. Status epilepticus as a first presentation of COVID-19 infection in a 3 years old boy; Case report and review the literature , 2020, IDCases.
[17] R. Blanc,et al. Correction to: COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features , 2020, Critical Care.
[18] J. García-Moncó,et al. Non-convulsive status epilepticus in a patient with COVID-19 infection , 2020, Clinical Neurophysiology.
[19] Jessica Falco-Walter,et al. Status epilepticus and other EEG findings in patients with COVID-19: A case series , 2020, Seizure.
[20] B. Millet,et al. Covid-19-related encephalopathy: a case series with brain FDG-PET/CT findings. , 2020, European journal of neurology.
[21] B. Hemmer,et al. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms , 2020, Journal of the Neurological Sciences.
[22] R. Kuzniecky,et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports , 2020, Journal of Neuroinflammation.
[23] S. Chacham,et al. Coronavirus Disease 2019 (COVID-19) Associated With Febrile Status Epilepticus in a Child , 2020, Cureus.
[24] C. Wharton,et al. Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease , 2020, BMJ Case Reports.
[25] J. Gaitanis,et al. COVID-19 Infection Presenting as Acute-Onset Focal Status Epilepticus , 2020, Pediatric Neurology.
[26] Jamshed Zuberi,et al. COVID-19 Precipitating Status Epilepticus in a Pediatric Patient , 2020, The American journal of case reports.
[27] A. Abdulsalam,et al. Generalized status epilepticus as a possible manifestation of COVID‐19 , 2020, Acta neurologica Scandinavica.
[28] P. Belani,et al. Rare presentations of COVID-19: PRES-like leukoencephalopathy and carotid thrombosis , 2020, Clinical Imaging.
[29] S. Meletti,et al. Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19 , 2020, Seizure.
[30] D. Leifer,et al. Posterior reversible encephalopathy syndrome in patients with COVID-19 , 2020, Journal of the Neurological Sciences.
[31] K. Demirkan,et al. COVID-19 & antiepileptic drugs: Should we pay attention? , 2020, Seizure.
[32] M. Tombini,et al. Electroencephalography at the time of Covid-19 pandemic in Italy , 2020, Neurological Sciences.
[33] V. Navarro,et al. Orbitofrontal involvement in a neuroCOVID‐19 patient , 2020, Epilepsia.
[34] F. Fatehi,et al. The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms , 2020, Journal of the Neurological Sciences.
[35] V. Aran,et al. Neuromechanisms of SARS-CoV-2: A Review , 2020, Frontiers in Neuroanatomy.
[36] D. Auer,et al. Delirium as a presenting feature in COVID-19: Neuroinvasive infection or autoimmune encephalopathy? , 2020, Brain, Behavior, and Immunity.
[37] V. Hernando-Requejo,et al. Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient , 2020, Seizure.
[38] I. Jelcic,et al. A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details , 2020, European journal of neurology.
[39] S. Hantus,et al. Acute Symptomatic Seizures in Critically Ill Patients with COVID-19: Is There an Association? , 2020, Neurocritical Care.
[40] W. Szurhaj,et al. Pay more attention to EEG in COVID-19 pandemic , 2020, Clinical Neurophysiology.
[41] P. Biban,et al. Self-limited focal epilepsy in a young child with SARS-CoV-2: serendipity or causal association? , 2020 .
[42] S. Pati,et al. De Novo Status Epilepticus in patients with COVID‐19 , 2020, Annals of clinical and translational neurology.
[43] Y. Péréon,et al. Non-lesional status epilepticus in a patient with coronavirus disease 2019 , 2020, Clinical Neurophysiology.
[44] Mitchell D Kilgore,et al. Neurological Impact of Coronavirus Disease of 2019: Practical Considerations for the Neuroscience Community , 2020, World Neurosurgery.
[45] S. Pavlakis,et al. Encephalitis Associated with COVID-19 Infection in an 11-Year-Old Child , 2020, Pediatric Neurology.
[46] Catello Vollono,et al. Focal status epilepticus as unique clinical feature of COVID-19: A case report , 2020, Seizure.
[47] R. D. Du Pasquier,et al. Two patients with acute meningoencephalitis concomitant with SARS‐CoV‐2 infection , 2020, medRxiv.
[48] T. Loddenkemper,et al. New‐onset refractory status epilepticus (NORSE) and febrile infection–related epilepsy syndrome (FIRES): State of the art and perspectives , 2018, Epilepsia.
[49] E. Gardella,et al. Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus – approach to clinical application , 2015, Epilepsy & Behavior.
[50] J. Boggs. Mortality Associated with Status Epilepticus , 2004, Epilepsy currents.
[51] J. Sung,et al. Detection of SARS Coronavirus RNA in the Cerebrospinal Fluid of a Patient with Severe Acute Respiratory Syndrome , 2003, Clinical chemistry.
[52] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.
[53] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .